Thiazole derivatives for treating PPAR related disorders

Details for Australian Patent Application No. 2002246713 (hide)

Owner Glaxo Group Limited

Inventors Cadilla, Rodolfo; Gosmini, Romain Luc Marie; Lambert, Millard Hurst III; Sierra, Michael Lawrence

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-B-2002246713

PCT Pub. Number WO2002/062774

Priority 0031107.6 20.12.00 GB

Filing date 19 December 2001

Wipo publication date 19 August 2002

Acceptance publication date 9 September 2004

International Classifications

C07D 277/26 Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings

A61K 031/10

A61P 003/10 Drugs for disorders of the metabolism

A61P 003/04 Drugs for disorders of the metabolism

A61P 003/06 Drugs for disorders of the metabolism

C07D 277/24 Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings

Event Publications

13 February 2003 Application Open to Public Inspection

  Published as AU-B-2002246713

9 September 2004 Application Accepted

  Published as AU-B-2002246713

13 January 2005 Standard Patent Sealed

16 July 2009 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002246714-3D DISPLAY DEVICES WITH TRANSIENT LIGHT SCATTERING SHUTTERS

2002246712-ADENYLYL AND GUANYLYL CYCLASES